Literature DB >> 30862604

Cortisol-induced SRSF3 expression promotes GR splicing, RACK1 expression and breast cancer cells migration.

Erica Buoso1, Melania Ronfani2, Marilisa Galasso2, Denise Ventura2, Emanuela Corsini3, Marco Racchi2.   

Abstract

Recent data have demonstrated that triple negative breast cancer (TNBC) with high glucocorticoid receptor (GR) expression are associated to therapy resistance and increased mortality. Given that GR alternative splicing generates mainly GRα, responsible of glucocorticoids action, we investigated its role in the regulation of RACK1 (Receptor for Activated C Kinase 1), a scaffolding protein with a GRE (Glucocorticoid Response Element) site on its promoter and involved in breast cancer cells migration and invasion. We provide the first evidence that GRα transcriptionally regulates RACK1 by a mechanism connected to SRSF3 splicing factor, which promotes GRα, essential for RACK1 transcriptional regulation and consequently for cells migration. We also establish that this mechanism can be positively regulated by cortisol. Hence, our data elucidate RACK1 transcriptional regulation and demonstrate that SRSF3 involvement in cells migration implies its role in controlling different pathways thus highlighting that new players have to be considered in GR-positive TNBC.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cortisol; GR; RACK1; SRSF3; TNBC

Mesh:

Substances:

Year:  2019        PMID: 30862604     DOI: 10.1016/j.phrs.2019.03.008

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  9 in total

1.  Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis.

Authors:  Jun Yao; Yu-Chen Tang; Bin Yi; Jian Yang; Yun Chai; Ni Yin; Zi-Xiang Zhang; Yi-Jun Wei; De-Chun Li; Jian Zhou
Journal:  J Cancer       Date:  2021-03-31       Impact factor: 4.207

Review 2.  Endocrine-Disrupting Chemicals' (EDCs) Effects on Tumour Microenvironment and Cancer Progression: Emerging Contribution of RACK1.

Authors:  Erica Buoso; Mirco Masi; Marco Racchi; Emanuela Corsini
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

Review 3.  The function and regulatory mechanism of RNA-binding proteins in breast cancer and their future clinical treatment prospects.

Authors:  Xingjia Lu; Jian Zhong; Linlin Liu; Wenzhu Zhang; Shengdi Zhao; Liang Chen; Yuxian Wei; Hong Zhang; Jingxuan Wu; Wenlin Chen; Fei Ge
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

4.  Predisposing factors for increased cortisol levels in oral cancer patients.

Authors:  Jéssica Araújo Figueira; Bruna Amélia Moreira Sarafim-Silva; Gislene Maria Gonçalves; Laerte Nivaldo Aranha; Flávia Lombardi Lopes; José Eduardo Corrente; Éder Ricardo Biasoli; Glauco Issamu Miyahara; Daniel Galera Bernabé
Journal:  Compr Psychoneuroendocrinol       Date:  2022-01-06

Review 5.  Proteostasis Deregulation in Neurodegeneration and Its Link with Stress Granules: Focus on the Scaffold and Ribosomal Protein RACK1.

Authors:  Mirco Masi; Alessandro Attanzio; Marco Racchi; Benjamin Wolozin; Sofia Borella; Fabrizio Biundo; Erica Buoso
Journal:  Cells       Date:  2022-08-19       Impact factor: 7.666

6.  Splicing Factor Transcript Abundance in Saliva as a Diagnostic Tool for Breast Cancer.

Authors:  Mercedes Bentata; Guy Morgenstern; Yuval Nevo; Gillian Kay; Avital Granit Mizrahi; Mark Temper; Ofra Maimon; Liza Monas; Reham Basheer; Asa Ben-Hur; Tamar Peretz; Maayan Salton
Journal:  Genes (Basel)       Date:  2020-08-03       Impact factor: 4.096

7.  FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis.

Authors:  Hua Yang; Lili Ren; Yanan Wang; Xuebing Bi; Xiaoli Li; Ming Wen; Qian Zhang; Yang Yang; Youchao Jia; Yumiao Li; Aimin Zang; Yaning Wei; Guanghai Dai
Journal:  Cell Death Dis       Date:  2020-10-13       Impact factor: 8.469

8.  E2F1 and epigenetic modifiers orchestrate breast cancer progression by regulating oxygen-dependent ESRP1 expression.

Authors:  Cheemala Ashok; Neha Ahuja; Subhashis Natua; Jharna Mishra; Atul Samaiya; Sanjeev Shukla
Journal:  Oncogenesis       Date:  2021-08-06       Impact factor: 7.485

Review 9.  Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy.

Authors:  Nikolay Mehterov; Maria Kazakova; Yordan Sbirkov; Boyan Vladimirov; Nikolay Belev; Galina Yaneva; Krassimira Todorova; Soren Hayrabedyan; Victoria Sarafian
Journal:  Genes (Basel)       Date:  2021-07-18       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.